UnitedHealth Group Incorporated (UNH) Stake Maintained by Palisades Hudson Asset Management L.P.

Palisades Hudson Asset Management L.P. continued to hold its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the first quarter, Holdings Channel reports. The fund owned 1,912 shares of the healthcare conglomerate’s stock at the end of the first quarter. Palisades Hudson Asset Management L.P.’s holdings in UnitedHealth Group were worth $314,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. State Street Corp increased its position in shares of UnitedHealth Group by 2.5% in the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock valued at $7,499,276,000 after buying an additional 1,122,534 shares in the last quarter. Legal & General Group Plc increased its position in shares of UnitedHealth Group by 5.4% in the first quarter. Legal & General Group Plc now owns 4,954,692 shares of the healthcare conglomerate’s stock valued at $812,630,000 after buying an additional 254,545 shares in the last quarter. Harris Associates L P increased its position in shares of UnitedHealth Group by 0.3% in the first quarter. Harris Associates L P now owns 4,646,307 shares of the healthcare conglomerate’s stock valued at $762,041,000 after buying an additional 14,489 shares in the last quarter. UBS Asset Management Americas Inc. increased its position in shares of UnitedHealth Group by 6.2% in the first quarter. UBS Asset Management Americas Inc. now owns 4,372,898 shares of the healthcare conglomerate’s stock valued at $717,199,000 after buying an additional 255,799 shares in the last quarter. Finally, American Century Companies Inc. increased its position in shares of UnitedHealth Group by 9.0% in the first quarter. American Century Companies Inc. now owns 4,022,002 shares of the healthcare conglomerate’s stock valued at $659,649,000 after buying an additional 333,338 shares in the last quarter. 86.21% of the stock is owned by hedge funds and other institutional investors.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded up 0.05% during midday trading on Thursday, hitting $193.87. 387,514 shares of the stock traded hands. The firm’s 50-day moving average is $190.13 and its 200 day moving average is $175.54. The company has a market capitalization of $187.44 billion, a price-to-earnings ratio of 23.29 and a beta of 0.64. UnitedHealth Group Incorporated has a 52 week low of $132.39 and a 52 week high of $196.04.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating analysts’ consensus estimates of $2.38 by $0.08. The business had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.96 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date of this dividend is Thursday, September 7th. UnitedHealth Group’s dividend payout ratio is presently 35.13%.

ILLEGAL ACTIVITY NOTICE: This piece of content was posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.com-unik.info/2017/08/17/unitedhealth-group-incorporated-unh-stake-maintained-by-palisades-hudson-asset-management-l-p.html.

Several equities analysts recently issued reports on UNH shares. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, June 28th. Deutsche Bank AG reissued a “buy” rating and set a $187.00 price target (up from $183.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Sanford C. Bernstein reissued an “outperform” rating and set a $190.00 price target on shares of UnitedHealth Group in a report on Monday, July 10th. Oppenheimer Holdings, Inc. reissued an “outperform” rating and set a $205.00 price target (up from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. Finally, Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Friday, May 19th. One investment analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $202.20.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,540 shares of the stock in a transaction that occurred on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total transaction of $990,219.60. Following the completion of the sale, the director now owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the sale, the director now directly owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Insiders have sold a total of 15,540 shares of company stock valued at $2,873,320 in the last three months. Insiders own 0.89% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

What are top analysts saying about UnitedHealth Group Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group Incorporated and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit